clinicalomicsprowebdirectory
Facebook
Linkedin
Twitter
News
Topics
Informatics
Molecular Dx
Patient Care
Oncology
Precision Medicine
Translational Research
Magazine
Browse Issues
Subscribe
Marketplace
Translational Research
Molecular Diagnostics
Oncology/Therapeutics
Healthcare Informatics
Subscribe
Get Inside Precision Medicine Magazine
Get Inside Precision Medicine eNewsletters
Multimedia
eBooks
Webinars
Summits
Learning Labs
Podcasts
Inside Precision Medicine Live
Search
Facebook
Linkedin
Twitter
Update Preferences
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Create an account
Privacy Policy
Create an account
Welcome! Register for an account
your email
your username
A password will be e-mailed to you.
Privacy Policy
Password recovery
Recover your password
your email
A password will be e-mailed to you.
Inside Precision Medicine
News
News & Features
Genetic Cause of Spinocerebellar Ataxia 4 Identified
News & Features
Cancer-Like Features in Atherosclerosis Provide New Opportunity for Treatment
Molecular Dx
Healthy Lifestyle Reduces Genetic Risk of Dying Early
News & Features
Gut Bacteria Can Help Create Artificial Group O Blood
Informatics
The Human Immunome Project Plans to Unlock the Immune System’s Secrets
Topics
Informatics
Molecular Dx
Patient Care
Oncology
Precision Medicine
Translational Research
Magazine
Browse Issues
Subscribe
Marketplace
Translational Research
Molecular Diagnostics
Oncology/Therapeutics
Healthcare Informatics
Subscribe
Get Inside Precision Medicine Magazine
Get Inside Precision Medicine eNewsletters
Multimedia
eBooks
Webinars
Summits
Learning Labs
Podcasts
Inside Precision Medicine Live
Inside Precision Medicine
CAR T-Cell Therapy with New Binding Method Shows Early Promise
Non-hodgkin's lymphoma
News & Features
CAR T-Cell Therapy with New Binding Method Shows Early Promise
Helen Albert
-
December 11, 2023
0
News & Features
Antibiotics Blunt CAR T Effect in Lymphoma Treatment
Malorye Branca
-
March 22, 2023
0
News & Features
Viruses that Cause Cancer Recruit Human Protein to Evade Immune Response
Chris Anderson
-
February 8, 2023
0
News & Features
Roche Bi-Specific Antibody Approved by FDA for a Relapsed or Refractory Form of Non-Hodgkin Lymphoma
Chris Anderson
-
December 27, 2022
0
News & Features
Single Cell Test Could Help Guide Cancer Therapy Selection
Helen Albert
-
October 15, 2021
0
News & Features
Caribou Biosciences’ IPO Hauls in $304M to Fund Development of Gene-Edited Cell Therapies
Chris Anderson
-
July 26, 2021
0
News & Features
New Class of Drugs Could Help Fight Lymphoma
Helen Albert
-
June 22, 2021
0
News & Features
New Immunotherapy Target Discovered for Non-Hodgkin Lymphoma
Chris Anderson
-
April 24, 2020
0
News & Features
Protein Inhibitor Could be New Approach for Treating Non-Hodgkin Lymphomas
Chris Anderson
-
January 8, 2020
0
Molecular Dx
Caris IDs potential Non-Hodgkins Lymphoma Drug Target
Chris Anderson
-
March 29, 2019
0
1
2
Page 1 of 2
Related Content
Walgreens Dives into Gene and Cell Therapy Delivery
Aspirin Enhances Colon Cancer Immunosurveillance
CAR T-Cell Therapy for Sarcoma Shows Early Promise
Using Nanoparticles for FZD4 to Lung Endothelial Cells Slows Lung Cancer Progression and Metastases
Inside Precision Medicine
![CRISPR Therapeutics and Massachusetts General Hospital Cancer Center said they will use CRISPR/Cas9 gene editing to develop novel T cell therapies for blood and solid tumors. [Source: Feng Zhang and Steve Dixo]](https://www.insideprecisionmedicine.com/wp-content/uploads/2019/01/1218.jpeg "Caribou Biosciences’ IPO Hauls in $304M to Fund Development of Gene-Edited Cell Therapies")
